Results 221 to 230 of about 311,648 (345)

Corrigendum: Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B

, 2010
Guevara-Garcia
openalex   +2 more sources

Chimeric protein with high antimicrobial activity

, 2017
Consejo Superior de Investigaciones Científicas (España)
Martínez Fernández, Beatriz, García-Suárez, María del Mar, Rodríguez González, Ana, Rodríguez, Lorena, Lavigne, Rob   +4 more
openaire   +2 more sources

Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives

Advanced Science, EarlyView.
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård, Tatiana Bobrova, Amalie Leinebø, Thibault Leray, Shayamita Ghosh, Lorena García‐Hevia, Chiara Puccinelli, Lorenzo Riccio, Jacopo Sorani, Davide Bonifazi, Julien Caumartin, Emmanuel Donnadieu, Florence Gazeau, Roland Hischier, Else Marit Inderberg, Mónica L. Fanarraga, Maria Loustau, Bernd Nowack, Sébastien Wälchli, Cécilia Ménard‐Moyon   +19 more
wiley   +1 more source

New Approaches to the Prevention of Visceral Leishmaniasis: A Review of Recent Patents of Potential Candidates for a Chimeric Protein Vaccine. [PDF]

Vaccines (Basel)
Oliveira DS, Zaldívar MF, Gonçalves AAM, Resende LA, Mariano RMDS, Pereira DFS, Conrado IDSS, Costa MAF, Lair DF, Vilas-Boas DF, Nakasone EN, Ameno IS, Goes WM, Silveira-Lemos D, Galdino AS, Nagem RAP, Dutra WO, Giunchetti RC.   +17 more
europepmc   +1 more source

A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection. [PDF]

Vaccines (Basel), 2022
Lage DP, Vale DL, Linhares FP, Freitas CS, Machado AS, Cardoso JMO, de Oliveira D, Galvani NC, de Oliveira MP, Oliveira-da-Silva JA, Ramos FF, Tavares GSV, Ludolf F, Bandeira RS, Pereira IAG, Chávez-Fumagalli MA, Roatt BM, Machado-de-Ávila RA, Christodoulides M, Coelho EAF, Martins VT.   +20 more
europepmc   +1 more source

Engineering chimeric signaling proteins for microbial whole-cell biosensors: from design to deployment

Güniz Özer Bergman, Sonia Mecacci, Vítor A. P. Martins dos Santos, Enrique Asin‐Garcia   +3 more
openalex   +1 more source

Ribosomal frameshifting at normal codon repeats recodes functional chimeric proteins in human [PDF]

Guiping Ren, Xiaoqian Gu, Lu Zhang, Shimin Gong, Shuang Song, Shunkai Chen, Zhenjing Chen, Xiaoyan Wang, Zhanbiao Li, Yingshui Zhou, Longxi Li, Yang Jiao, Fan Lai, Yunkun Dang   +13 more
openalex   +1 more source

Comprehensive in silico allergenicity assessment of novel protein engineered chimeric Cry proteins for safe deployment in crops [PDF]

, 2017
Maniraj Rathinam, Shweta Singh, Debasis Pattanayak, Rohini Sreevathsa   +3 more
openalex   +1 more source

ESCRT‐Mimetic Nanodegrader Targets STING for Anti‐Inflammatory Therapy

Advanced Science, EarlyView.
A nanoplatform‐enabled targeted protein degradation strategy is presented to regulate aberrant STING signaling. STING‐ATTEC induces selective autophagic degradation of STING via formation of a STING–ATTEC–LC3 ternary complex, while the cationic FA‐LNP+ system enhances LC3 generation and targeted delivery. Together, this synergistic approach efficiently
Fuyuan Zhou, Qiming Zhai, Zhihao Yao, Qing Li, Yan Yang, Si Wang, Chao Huang, Liangjing Xin, Tao Chen, Jinlin Song   +9 more
wiley   +1 more source

Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling. [PDF]

Oncogene
Dupuy M, Gueguinou M, Postec A, Brion R, Tesfaye R, Mullard M, Regnier L, Amiaud J, Hubsch C, Potier-Cartereau M, Chantôme A, Brounais-Le Royer B, Baud'huin M, Georges S, Lamoureux F, Ory B, Entz-Werlé N, Delattre O, Rédini F, Vandier C, Verrecchia F.   +20 more
europepmc   +1 more source